Literature DB >> 23838867

Perioperative statin therapy is not associated with reduced risk of anastomotic leakage after colorectal resection.

Anne Sofie Bisgård1, Morten Westergaard Noack, Mads Klein, Jacob Rosenberg, Ismail Gögenur.   

Abstract

BACKGROUND: Anastomotic leakage is a serious complication of colorectal surgery. Several studies have demonstrated the beneficial pleiotropic effects of statins, and preliminary studies have suggested that perioperative statin treatment may be associated with reduced risk of anastomotic leakage.
OBJECTIVE: We aimed to investigate whether perioperative statin therapy was associated with a reduced anastomotic leakage rate after colorectal resections with primary anastomosis.
DESIGN: The study was based on prospectively collected data from the Danish Colorectal Cancer Group and electronically registered medical records holding information on perioperative statin therapy. SETTINGS: Data were collected from the 6 major surgical centers responsible for all elective colorectal cancer surgery in the eastern part of Denmark. PATIENTS: We collected data on 2766 patients with electronically registered medical records who underwent resection of the colon or rectum with primary anastomosis from 2006 to 2009. MAIN OUTCOME MEASURE: The primary outcome measured was anastomotic leakage requiring surgical intervention.
RESULTS: Five hundred eighteen patients (19%) were treated with statins perioperatively. Four hundred ninety-six patients received statins both before and after surgery. Fifty-two patients (10.5%) received high-dose statin therapy. Possible risk factors for anastomotic leakage were identified via univariate regression analyses. In subsequent multivariate analysis, perioperative statin therapy was not associated with reduced anastomotic leakage rate (OR (95% CI) 1.31 (0.84-2.05), p = 0.23). We identified intraoperative blood transfusion, rectal resection (versus colonic), male sex, and tobacco usage as risk factors for anastomotic leakage in the multivariate analysis. LIMITATIONS: This study is limited by its observational design and missing data on comorbidities and BMI.
CONCLUSION: Perioperative statin therapy was not significantly associated with reduced anastomotic leakage rate after colorectal resection with primary anastomosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838867     DOI: 10.1097/DCR.0b013e318298252f

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Statin use is not associated with improved 30-day survival in patients undergoing surgery for colorectal cancer.

Authors:  Tina Fransgaard; Lau Caspar Thygesen; Ismail Gögenur
Journal:  Int J Colorectal Dis       Date:  2017-12-21       Impact factor: 2.571

2.  Prophylactic transanal decompression tube versus non-prophylactic transanal decompression tube for anastomotic leakage prevention in low anterior resection for rectal cancer: a meta-analysis.

Authors:  Yun Yang; Ye Shu; Fangyu Su; Lin Xia; Baofeng Duan; Xiaoting Wu
Journal:  Surg Endosc       Date:  2016-09-12       Impact factor: 4.584

3.  Statin therapy and postoperative short-term mortality after rectal cancer surgery.

Authors:  Arvid Pourlotfi; Rebecka Ahl; Gabriel Sjolin; Maximilian Peter Forssten; Gary A Bass; Yang Cao; Peter Matthiessen; Shahin Mohseni
Journal:  Colorectal Dis       Date:  2020-12-23       Impact factor: 3.788

4.  Postoperative use of hypnotics is associated with increased length of stay after uncomplicated surgery for colorectal cancer.

Authors:  Morten Westergaard Noack; Anne Sofie Bisgård; Mads Klein; Jacob Rosenberg; Ismail Gögenur
Journal:  SAGE Open Med       Date:  2016-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.